On Monday, Shares of General Electric Company (NYSE:GE), lost -1.76% to $26.31.
GE Capital, Canada and Gaz Métro Transport Solutions (GMTS), a partner of Gaz Métro, declared the signing of a planned agreement that will facilitate the trucking industry’s adoption of natural gas as a fuel in Eastern Canada . GE Capital has been providing wholesale and retail financing to the country’s commercial trucking sector for 35 years. Since its creation in 2010, GMTS has become a leader in the alternative fuels space in Quebec , both for the advisory role it provides to companies and for its deployment of natural gas refueling stations.
Under this agreement, fleet operators will work with GMTS for natural gas supply and purchase and, separately, with GE Capital to secure loans or leases for natural gas vehicles (NGVs). NGVs that are eligible under this agreement use either compressed natural gas (CNG) or liquefied natural gas (LNG).
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.
Shares of Mylan N.V. (NASDAQ:MYL), inclined 0.90% to $70.75, during its last trading session, as Teva Pharmaceutical Industries Ltd. (TEVA) plans to enhance its bid for the drug maker as soon as this week, according to Bloomberg.
Teva may offer $86 to $88 per share for Mylan, up from the $82 per share it bid in April, Bloomberg stated.
Mylan rebuffed Teva’s $40 billion bid in April, saying it grossly undervalued the company, and pressed on with its own $34 billion hostile bid for Perrigo Co Plc (PRGO.N) in an attempt to fend off Teva’s interest.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Finally, Baidu, Inc. (NASDAQ:BIDU), ended its last trade with -4.06% loss, and closed at $189.03.
iQIYI, an independently operated partner of Baidu, and one of the largest internet and mobile video service providers in China, declared that the company’s mobile app has become No.1 in the free app popularity rankings and No.2 among all the apps in the China Apple App store, driven by the popularity of iQIYI self-produced content.
On July 3, iQIYI released the full series of its self-produced TV show The Lost Tomb to its paid subscribers. In order to watch the full series, a huge number of users downloaded the iQIYI app and purchased the subscription service, with the number of user clicks on The Lost Tomb episodes surpassing 160 million within five minutes following the release. Since its release, episodes of The Lost Tomb have been viewed over one billion times.
“Providing access to premium online TV content to paid subscribers is a promising new frontier in China’s online-video industry,” said Yu Gong, founder and CEO of iQIYI. “The success of The Lost Tomb demonstrates the huge potential of iQIYI’s subscription service to drive enormous traffic to our platform by providing high-quality content and excellent user experience.”
Baidu, Inc. provides Internet search services in China and internationally. It offers Chinese language search platform on its Baidu.com Website that enables users to find relevant information online, counting Web pages, news, images, documents, and multimedia files through links offered on its Website; and international products and services to users in other countries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
